Division 55 became eligible to submit candidates for APA Fellow status as of 2002. The following list includes those who submitted applications and were accepted by the Division and the APA Membership Committee as new Fellows of APA. It also includes those whose names were submitted as current Fellows (already held Fellow status in APA but the Division wanted to recognize them as well). Congratulations to all!

Robert Ax
Jeffrey Barnett
Patricia Bricklin
Ronald T Brown
Mathilda B Canter
Victor de la Cancela
Patrick H DeLeon
Debra Dunivin
Dan Egli
Michael F Enright
Alan Entin
Raymond Folen
Dr Ronald E Fox
Lisa Grossman
Alan Gruber
Ronald F Levant
Elaine S LeVine
Leland Lipp
Elaine Orabano Mantell
E Mario Marquez
Robert E McGrath
Kathleen M. McNamara
Matthew B Nessetti
Robert J. Resnick
David A. Rodgers
Michael J Salamon
Morgan Sammons
Gil Sanders
A. Eugene Shapiro
Tommy Stigall
Michael Sullivan
Danny Wedding
Jack G Wiggins
Deanna F. Yates

Application For Fellow Status

Division 55 welcomes applications for APA Fellow status for the 2007 cycle. The Division can consider both individuals who are not presently a Fellow in APA (new Fellow), and those who have been awarded Fellow status through another Division but are also members of Division 55 (current Fellow). The criteria adopted by the Board of Division 55 are noted below. Please be sure to note that the Division must document how your contributions are unusual and outstanding and how they have had national significance.

If you wish to be considered as a candidate for "new" Fellow status, please send an email requesting an application packet to: Dr. Alan Gruber.  In the heading of your e-mail, please include the words "Div 55 New Fellow." The packet includes a letter explaining the process and the requirements, as well as the APA Membership Office application and endorsement forms. 

If you wish to be considered as a "current" Fellow, please submit a very brief statement indicating your desire to be considered for current Fellow status, and note which of the Division's criteria your work in the Pharmacotherapy area would address and how.  Included in the statement should be your name as it appears in the APA membership database, your APA membership number, and the Division(s) through which you already have been awarded Fellow status. This statement may also be sent to Dr. Gruber, and should be addressed To: Fellows Committee, Division 55.

If you have any questions, please contact Dr. Gruber via the email links above.

Division 55
American Society for the Advancement of Pharmacotherapy
Fellow Criteria

In keeping with the Bylaws and membership criteria of Division 55, individuals considered for Fellowship status must provide evidence of unusual and outstanding contributions to Psychopharmacotherapeutic practice at the national level. Evidence of unusual and outstanding contributions may be seen in the member’s direct herapeutic services, in consultation, education or administrative arenas; through leadership and contributions within professional associations, involvement in governance, legislative or regulatory activities at the local, state, regional, or national level; or, in scholarly work, including but not limited to workshops or presentations at professional meetings, research or publications. In all instances, the Division’s Fellows Committee and the Board of Directors must concur that the candidate’s evidence demonstrates an outstanding ontribution.Evidence which could meet this standard of excellence may include:

1. Advancing the appropriate expansion of the scope of psychological practice through focused and concerted advocacy efforts and/or within systems of health care delivery

2. Recognition for leadership in addressing issues relating to psychopharmacotherapy practice in professional meetings and/or other public settings (e.g. legislatures, public forums sponsored by consumer groups, etc.), and/or through service on national committees, task forces, steering groups, or other similar panels

3. Having established or directed an organized and recognized program for the education and training of psychologists in psychopharmacotherapy practice; or, having participated as an instructor or supervisor in such programs or other continuing education programs at a level beyond the usual demands of such a position and in a manner which would have national impact (e.g. covering a unique applications; serving as guest lecturer at various programs nationally or internationally, etc.)

4. Public recognition (i.e. awards, honorary titles, invited addresses, etc.) as an authority and/or leader in the area of psychopharmacotherapy for psychologists

5. Author, co-author, or editor of scholarly work(s) in peer-reviewed or refereed publications, which are recognized as having a major or national impact and/or having been a guiding influence on the immediate or future aspects of this area of practice; or, such work which has lead to advancement of this area in curricular, regulatory or legislative, or socio-political arenas, which may include public education and information

6. Advancing the knowledge area within psychopharmacotherapy through: leadership in a specific and unique area of investigation or research, encouraging and/or mentoring other psychological investigators within this area of study, or participation in review panels or grant preparation which facilitates the recognition of psychologists’ general practice and/or unique practice in this area

7. Development of innovative practice techniques or methods of service delivery that are recognized and/or used by other practitioners.